We describe a case of severe left ventricular outflow tract obstruction (LVOTO) with severe mitral incompetence due to systolic anterior motion of the anterior mitral leaflet (SAM) that was recognised thanks to the immediate availability of transoesophageal echocardiography during the resuscitation of anaphylactic shock. The patient rapidly responded to cessation of the epinephrine (adrenaline) infusion and intravascular volume expansion with intravenous crystalloid. The absence of risk factors for developing SAM/LVOTO serve as a warning to clinicians to consider this diagnosis in all cases of epinephrine nonresponsive anaphylactic shock.
Why some patients, often without known comorbidities and with presumably good physiological reserve, suffer fatal intraoperative anaphylaxis while others survive is a topic of frequent discussion. We report the case of a 54-year-old man who suffered anaphylaxis shortly after anaesthetic induction, a case that demonstrates a previously unrecognised cause of epinephrine (adrenaline) non-responsive shock. The insights from this never-previously-reported complication of anaphylaxis may require us to reconsider the role of epinephrine in non-responsive anaphylactic shock, and highlights the importance of aggressive volume resuscitation.
Case
A 54-year-old man with membranous glomerulonephritis on home haemodialysis was anaesthetised for livedonor renal transplantation. He had been anaesthetised uneventfully in previous years for a hemicolectomy for colon cancer and sleeve gastrectomy for obesity. His medical history included hypertension (resolved with weight loss), hypercholesterolaemia and gout, and his only medications were frusemide, calcium, rosuvastatin, nicotine (transcutaneous patch) and mycophenolate. He had a distant history of allergy to penicillin as a child and angioedema with perindopril. Preoperative investigations included a normal dipyridamole/treadmill stress myocardial perfusion scan (with normal 3D gated cine left ventricular wall motion) and normal resting transthoracic echocardiograms.
Anaesthesia was induced with titrated propofol, fentanyl and vecuronium, his trachea was intubated and anaesthesia maintained with desflurane in an air/oxygen mix. A urinary catheter was inserted and the patient positioned for a right internal jugular central line after skin preparation with 2% chlorhexidine in alcohol. Approximately 20 minutes after induction, during the process of insertion of a nonimpregnated central line, the patient developed severe hypotension (systolic blood pressure 50 mmHg), resistant to multiple boluses of metaraminol and then intravenous epinephrine (100 microgram boluses to a total of 600 micrograms). An infusion of epinephrine was commenced at 10 micrograms per minute and an additional 500 ml bolus of compound sodium lactate was administered in addition to the 500 ml that had already been administered. He remained hypotensive (systolic blood pressure 80 mmHg) with a sinus tachycardia (120 per minute) and had started to develop signs of reduced cardiac output (end-tidal carbon dioxide fell from 40 mmHg to 28 mmHg) and tissue hypoperfusion (peripheral oxygen saturation 90%). There was no rash or change in respiratory compliance. In view of his deteriorating condition, a transoesophageal echocardiogram was performed. This revealed that his left ventricle was hyperdynamic, without regional wall motion abnormalities or apical dilatation, and with low end-diastolic and end-systolic volumes. There was turbulence in the left ventricular outflow tract with late-peaking raised velocities (3.4 m/s; peak left ventricular outflow tract gradient 46 mmHg in the setting of severe mitral regurgitation, severe hypotension and low cardiac output) and severe eccentric mitral regurgitation (see Figure 1) . A diagnosis of left ventricular outflow tract obstruction (LVOTO) with severe mitral incompetence due to systolic anterior motion of the anterior mitral leaflet (SAM) was made (see supplementary video file). There was prolonged mitral leaflet-septal contact for greater than 60% of the ventricular ejection time, categorising this SAM in the highest grade of severity (>30% contact time). The epinephrine infusion was ceased, and a further bolus of 500 ml of compound sodium lactate infused. His condition rapidly improved with these interventions, echocardiography demonstrating a reduced severity of the mitral regurgitation, a reduction in the duration of mitral leaflet-septal contact and reduced severity of the outflow tract obstruction (see Figure 2 , upper image). A norepinephrine (noradrenaline) infusion was commenced, but following additional intravenous fluid (2,000 ml PlasmaLyte 148, Baxter Healthcare, Toongabbie, New South Wales) it was able to be weaned 30 minutes after the commencement of resuscitation. Renal transplantation proceeded and was successful. He was extubated four hours after induction and monitored in a high dependency unit overnight. An acute ImmunoCAP tryptase (Phadia 250, Phadia Ab, Uppsala, Sweden) was markedly raised (71.8 μg/l), with a normal preoperative value (10.2 μg/l) and the postoperative value returning to baseline (5.1 μg/l).
A transthoracic echocardiogram performed the following day did not demonstrate any mitral incompetence, LVOTO or risk factors for developing SAM (see Figure 2 , lower image). His basal inferior septum measured 10 mm, with a mitralaortic angle of 150 degrees, septal to coaptation distance of 31 mm, posterior mitral leaflet length of 16 mm (anterior mitreal leaflet (AML):posterior mitral leaflet (PML) 1.5), normal end-diasolic left ventricular diameter (5.1 cm) and a low-normal left ventricular ejection fraction (48%). He was discharged from hospital on day 4, but represented on day 6 with a rising creatinine. Acute transplant rejection was managed with additional immunosuppression and he went on to made an excellent recovery. Chlorhexidine-specific IgE titres were raised in serum (0.98 kU/L; Phadia 250, Phadia Ab, Uppsala, Sweden). No potential triggers for anaphylaxis tested positive to intradermal testing except for chlorhexidine (1:1,000 dilution of aqueous 0.2% chlorhexidine) which produced an 8 mm wheal with flare, confirming the clinical diagnosis of anaphylaxis to chlorhexidine skin preparation potentially introduced during insertion of an internal jugular central line.
The patient gave permission for the events and his personal medical history to be published.
Discussion
This report demonstrates a new mechanism for epinephrine non-responsive anaphylactic shock in a patient who had no structural heart abnormalities predisposing him to LVOTO or SAM.
Dynamic SAM is a consequence of systolic anterior motion of the anterior mitral valve leaflet 1 . SAM/LVOTO describes the anterior motion of one or both leaflets of the mitral valve during systole, resulting in narrowing of the left ventricular outflow tract with turbulence and a subaortic gradient which is maximal in late systole. Mitral leaflet coaptation may also be disrupted, causing mitral regurgitation and pulmonary congestion with a further reduction in cardiac output. SAM most commonly occurs in patients with asymmetrical septal hypertrophy, but may be present in approximately one percent of patients with cardiac disease without septal hypertrophy 2 , or even in patients with no history of cardiac disease 3 . In the latter, it has been described in individuals provoked by exercise-or dobutamine-stress echocardiography, phaeochromocytoma, catecholamine treatment, lung transplantation, liver transplantation, and septic shock 4, 5 . SAM may be categorised into four grades of increasing severity based on the echocardiographic appearance of leaflet motion; this case fulfilled the criteria for the most severe grade 6 . There is no consensus for the identification of patients without asymmetrical septal hypertrophy (septal wall thickness less than or equal to 15 mm) who are at risk for SAM/LVOTO. When provoked by exercise, risk factors include chordal SAM, small LV cavity size, a hyperdynamic left ventricle and younger age 4 . In the elderly, stress-induced SAM is more likely in those with a reduced septo-aortic angle 3 or sigmoid septum 7 . After mitral valve replacement, a bulging septum (ventricular septal thickness of greater than 13 mm or basal to mid-ventricular septal ratio greater than or equal to 1.3), a long posterior mitral leaflet (>19 mm or AML:PML <1.3), an anteriorly displaced mitral leaflet coaptation point (septal to coaptation distance <25 mm), and mitral-aortic angle ≤130 degrees are significant 8, 9 . Takotsubo syndrome has also been complicated by left ventricular outflow tract obstruction 10 . It is notable that our patient had none of these structural heart abnormalities.
Anaphylactic shock results in conditions ideally suited to the development of SAM/LVOTO. Anaphylactic mediators cause vasodilation and reduced afterload, increased venous capacitance and the loss of fluid from the intravascular space into the interstitium 11 . Endogenous epinephrine plasma concentrations increase fivefold in the first minutes of anaphylaxis as a result of sympathoadrenal stimulation 12 . This is further compounded by the first-line treatment for anaphylaxis-intravenous or intramuscular epinephrinethe physiological antidote to the neurohumoral effects of mast cell degranulation. Alpha-adrenoreceptor stimulation ameliorates reduced peripheral vascular resistance, venous tone and angioedema, and beta 2-adrenoreceptor stimulation causes bronchodilation and a reduction in the release of inflammatory mediators from mast cells 13 . In untreated anaphylaxis in man, the reduction in systemic vascular resistance with anaphylaxis coincides with an increase in cardiac output and stroke volume, either in response to histamine release or sympathoadrenal stimulation 12 . Histamine has been shown to have direct positive inotropic and chronotropic actions, and it is not clear that the beta 1-adrenoreceptor effect of exogenous epinephrine provides additional benefit to the observed large increases in endogenous catecholamines 12 . In a dog model of anaphylactic shock, the beneficial effect of intravenous epinephrine on blood pressure was secondary to improved preload (increase in pulmonary capillary wedge pressure) causing increased stroke volume and cardiac output 14 . Nonetheless, in humans the use of epinephrine in anaphylaxis is based on extrapolation from first principles rather than based on clinical evidence 15 . The importance of detecting SAM/LVOTO is that aspects of the treatment protocols for SAM/LVOTO and anaphylaxis are contradictory. SAM/LVOTO responds to cessation of catecholamine administration, administration of negative inotropes (beta-blockade), and/or ventricular pacing to increase left ventricular end-diastolic volume. As mentioned, epinephrine is the mainstay of the management of anaphylaxis, and beta-blockade is contraindicated as it is known to be an independent risk factor for the severity and prevalence of acute anaphylaxis 16 . The authors believe that if SAM/LVOTO does complicate anaphylaxis, the focus should shift from epinephrine administration to fluid resuscitation (to restore preload) and vasoconstrictors (to increase afterload). In this case, the initial fluid resuscitation was less than recommended by local guidelines, and likely contributed to the poor response to epinephrine 17 . It is also recognised that epinephrine non-responsive shock may require the use of alternative vasoconstrictors-such as vasopressin, glucagon or methylene blue-and these may have been particularly beneficial in this case. These non-epinephrine therapies will counteract both the major pathophysiological features of anaphylaxis (reduced preload and afterload) and SAM/LVOTO (by increasing left ventricular volume in late systole).
In our region, echocardiography is not generally immediately available during resuscitation from anaphylaxis. As anaphylaxis results in conditions ideal for the development of SAM/LVOTO, and this case demonstrates the possibility of it occurring in a structurally normal heart, it is possible that dynamic SAM/LVOTO is common and unrecognised. Dynamic SAM/LVOTO without septal hypertrophy will not be apparent on preoperative or postoperative echocardiography, or even post mortem examination. As epinephrine administration in this case was demonstrably causing harm, it is possible that such cases, if undiagnosed, may represent cases of severe anaphylaxis or those that are epinephrine-resistant. This hypothesis is supported by a coincidence of risk factors for each condition. Analysis of fatal anaphylaxis in 4.1% of the 1,247 cases of severe anaphylaxis in France from 2000 to 2011 found that male gender (P=0.0004), advanced age (P=0.001), a history of hypertension (P=0.001), diabetes (P=0.03), or obesity (P=0.0055) were associated with increased risk of death 18 . A second French study from 2012 to 2014 described three cases of fatal intraoperative anaphylaxis in which all received intravenous epinephrine but none received adequate volume resuscitation 19 . A study of fatal reactions after muscle relaxant anaphylaxis in the UK repeated the finding that male gender was a risk factor (P=0.02) 20 . Advanced age, male gender and coexisting hypertensive disease are also recognised risk factors for SAM/ LVOTO 1 . Diabetes is also a known risk factor due to excessive responsiveness to beta-adrenergic agents 3 . If we assume that our hypothesis is true, we may predict a second peak of increased anaphylaxis severity or excess mortality in youth, as younger age has been described as a risk factor for exerciseinduced SAM/LVOTO 4 . In summary, we describe the first case of severe LVOTO with severe mitral incompetence due to SAM that was recognised with transoesophageal echocardiography during the resuscitation of anaphylactic shock. The patient rapidly responded to cessation of the epinephrine infusion and intravascular volume expansion with intravenous crystalloid. The absence of risk factors for developing SAM/LVOTO serve as a warning to clinicians to consider this diagnosis in all cases of epinephrine non-responsive anaphylactic shock. It is possible that dynamic SAM/LVOTO is being underdiagnosed in anaphylaxis, and is a possible explanation for epinephrine non-responsiveness or poor resuscitation outcome. Echocardiography should be a component of the resuscitation from epinephrine non-responsive shock and clinicians should remember that aggressive volume expansion is a key component of the management of anaphylaxis.
Supplementary video file
A short video available for download from the AIC Journal website demonstrates the characteristic appearance of systolic anterior motion of the anterior leaflet of the mitral valve with left ventricular outflow tract obstruction, using loops taken from this case. Note that the frame rate is reduced by half to improve clarity (edited and captioned by Miss Amelie R. Sadleir).
